MedPath

Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.

Recruiting
Conditions
Respiratory Distress Syndrome
Interventions
Drug: Nitric oxide
Behavioral: prone positioning
Registration Number
NCT05715788
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.

Detailed Description

The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS. Patients with COVID-19-associated ARDS were ventilated in prone position with or without NO inhalation, the arterial blood gas (ABG) tests were performed at 16 hours after prone positioning.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Adult patients with COVID-19 associated ARDS
Read More
Exclusion Criteria
  • patients who have contraindication for prone positioning, including pregnant, post-abdomen surgery within a week; hypercapnic respiratory failure
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients ventilated in prone position with NO inhalationprone positioningPatients ventilated in prone position with NO inhalation
patients ventilated in prone positionprone positioningPatients ventilated in prone position
Patients ventilated in prone position with NO inhalationNitric oxidePatients ventilated in prone position with NO inhalation
Primary Outcome Measures
NameTimeMethod
P/F ratio16 hours

P/F ratios in each group

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Zhongshan Hospital, Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath